Elicio Therapeutics (ELTX)

• Market cap: $135M
• 1 day: -3.21%
• 5 days: -4.38%
• 1 month: -0.13%
• 3 months: -14.21%
• 6 months: -20.95%
• Year to date: -2.48%
• 1 year: -14.86%
• 5 years: -95.39%
• 10 years: -95.39%
• Sector: Healthcare
• Industry: Biotechnology

About: Elicio Therapeutics Inc is a clinical-stage biotechnology company pioneering the development of cancer immunotherapies for patients with limited treatment options and poor outcomes. Its proprietary Amphiphile, or AMP, platform delivers investigational immunotherapeutics directly to the brain center of the immune system the lymph nodes. Its focus is the development of cancer immunotherapies against biologically validated but hard-to-drug targets that can be activated through lymph node trafficking.

Employees: 26